Click for best price
Skin Cancer Molecular Diagnostics Market Size, Share 2023
A molecular approach for diagnosing skin cancer
This report aims to provide a comprehensive presentation of the global market for Skin Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Cancer Molecular Diagnostics. This report contains market size and forecasts of Skin Cancer Molecular Diagnostics in global, including the following market information:
Global Skin Cancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Skin Cancer Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Skin Cancer Molecular Diagnostics include Inmedi, Roche and Annoroad, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Skin Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Skin Cancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Skin Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Skin Cancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Skin Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Skin Cancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Skin Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Skin Cancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Skin Cancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Inmedi
Roche
Annoroad
Outline of Major Chapters:
Chapter 1: Introduces the definition of Skin Cancer Molecular Diagnostics, market overview.
Chapter 2: Global Skin Cancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Skin Cancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Skin Cancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Skin Cancer Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Skin Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Skin Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Skin Cancer Molecular Diagnostics Overall Market Size
2.1 Global Skin Cancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Skin Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Skin Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Skin Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Skin Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Skin Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Skin Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Skin Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Skin Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Skin Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Skin Cancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Skin Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Skin Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Skin Cancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Skin Cancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Skin Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Skin Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Skin Cancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Skin Cancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Skin Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Skin Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Skin Cancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Skin Cancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Skin Cancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Skin Cancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Skin Cancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Skin Cancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Skin Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Skin Cancer Molecular Diagnostics Market Size, 2018-2030
7 Skin Cancer Molecular Diagnostics Companies Profiles
7.1 Inmedi
7.1.1 Inmedi Company Summary
7.1.2 Inmedi Business Overview
7.1.3 Inmedi Skin Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Inmedi Skin Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Inmedi Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Skin Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Roche Skin Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Annoroad
7.3.1 Annoroad Company Summary
7.3.2 Annoroad Business Overview
7.3.3 Annoroad Skin Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Annoroad Skin Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Annoroad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Skin Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Skin Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Skin Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Skin Cancer Molecular Diagnostics in Global Market
Table 5. Top Skin Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Skin Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Skin Cancer Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Skin Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Skin Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Skin Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Skin Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Skin Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Skin Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Skin Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Skin Cancer Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Skin Cancer Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Inmedi Company Summary
Table 31. Inmedi Skin Cancer Molecular Diagnostics Product Offerings
Table 32. Inmedi Skin Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Inmedi Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Skin Cancer Molecular Diagnostics Product Offerings
Table 36. Roche Skin Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Annoroad Company Summary
Table 39. Annoroad Skin Cancer Molecular Diagnostics Product Offerings
Table 40. Annoroad Skin Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Annoroad Key News & Latest Developments
List of Figures
Figure 1. Skin Cancer Molecular Diagnostics Segment by Type in 2022
Figure 2. Skin Cancer Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Skin Cancer Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Skin Cancer Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Skin Cancer Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Skin Cancer Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Skin Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Skin Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Inmedi Skin Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Skin Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Annoroad Skin Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
